Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors

Cited 24 time in scopus
Metadata Downloads
Title
Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors
Author(s)
Hwan Mook Kim; S H Hong; M S Kim; Chang Woo LeeJong Soon Kang; Kiho Lee; Song Kyu Park; J W Han; H Y Lee; Y Choi; H J Kwon; G Han
Bibliographic Citation
Bioorganic & Medicinal Chemistry Letters, vol. 17, no. 22, pp. 6234-6238
Publication Year
2007
Abstract
Novel δ-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities.
Keyword
Anticancer chemotherapyDocking modelEnzyme inhibitorGrowth inhibitionHDACHistone deacetylaseIn vivo xenograft model
ISSN
0960-894X
Publisher
Elsevier
DOI
http://dx.doi.org/10.1016/j.bmcl.2007.09.034
Type
Article
Appears in Collections:
Ochang Branch Institute > Division of Bioinfrastructure > Laboratory Animal Resource Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.